The vaccination strategy using Rhiniseng® and Hiprasuis® Glasser significantly enhanced performance, demonstrating superior ADWG, improved FCR, and reduced mortality throughout both the nursery and fattening phases. The lower incidence of pleurisy and the improved atrophic rhinitis index support the efficacy of the vaccination program compared to antibiotic use. These results suggest that vaccination against non-progressive atrophic rhinitis contributes to reducing the incidence of S.suis in piglets. An economic return on investment of 8.82 indicates that these strategies not only improve animal health but also enhance the profitability of swine production.
Synergistic effects of atrophic rhinitis and glässer disease vaccination on pig performance
Publications
Swine
This study aimed to assess the effectiveness and productivity impact of comprehensive vaccination strategies against Bb, Pasteurella multocida type D, and Gp on pig performance and the overall economic benefit of the farm, as an alternative to the prophylactic use of antibiotics during both the nursery and fattening phase.
Download this article
Related products
The first intradermal needle-free vaccine against Mycoplasma hyopneumoniae and PCV2, all in one, in suspension for injection
Live vaccine against porcine reproductive and respiratory syndrome (PRRS), in injectable freeze-dried tablet
Purified recombinant verotoxin 2e against edema disease, in suspension for injection
Inactivated vaccine, against progressive and non progressive swine atrophic rhinitis, in injectable suspension.
Inactivated vaccine against neonatal colibacillosis and Clostridium infections in swine, in injectable suspension
Inactivated vaccine against Clostridioides difficile and Clostridium perfringens type A infections in swine, in injectable suspension.
Inactivated vaccine against porcine parvovirus and swine erysipelas, in injectable suspension
Inactivated vaccine against swine erysipelas, parvovirosis and leptospirosis, in injectable suspension
Live vaccine against Aujeszky’s disease gE negative strain, in injectable freeze-dried tablet
Inactivated vaccine against swine erysipelas, in injectable suspension
Inactivated porcine against porcine parvovirus, in injectable suspension
Inactivated vaccine against enzootic pneumonia, in injectable suspension
Related services
Smart Vaccination by HIPRA is a revolutionary concept that combines: A smart vaccine including RFID technology in its label, a vaccination device which ensures precision and efficiency, and a new world of digital solutions in HIPRAlink Vaccination. All these elements are developed internally by HIPRA.
In Swine, the HIPRA SMART VACCINATION is spearheaded by our innovative MHYOSPHERE® PCV ID and UNISTRAIN® PRRS vaccines, the needle-free intradermal device Hipradermic® and the professional veterinary app HIPRAlink® Vaccination.
An innovative service based on data analysis that facilitates decision-making in swine
HIPRA Stats is a data analysis service for animal production companies.
Hipradermic® is an advanced needle-free injection device with wireless connectivity for the intradermal vaccination of pigs.
HIPRA University offers high quality training programmes in strategic areas of interest for professionals
Access an advanced diagnostic service with maximum comfort and reliability
